Related Experiment Video
Updated: Jun 26, 2025
07:23
Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
Published on: December 3, 2016
12.0K
Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway
Takuro Hakata1, Yohei Ueda1, Takafumi Yamashita2
1Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
Endocrinology
|May 16, 2024
Summary
Inhibiting neprilysin (NEP) with sacubitril promotes skeletal growth by increasing C-type natriuretic peptide (CNP) levels. This approach shows promise for treating impaired growth conditions.
Area of Science:
- Skeletal Biology
- Pharmacology
- Endocrinology
Background:
- C-type natriuretic peptide (CNP) is vital for endochondral bone growth.
- CNP's short half-life limits its therapeutic potential for skeletal growth disorders.
- Neprilysin (NEP) degrades CNP, making it a target for extending CNP's action.
Purpose of the Study:
- To investigate the effect of NEP inhibition on skeletal growth.
- To determine if NEP inhibition can enhance bone growth through the CNP pathway.
Main Methods:
- Administered sacubitril (a NEP inhibitor) to C57BL/6 mice.
- Conducted histological analysis of growth plates.
- Utilized knockout mice lacking cartilage-specific natriuretic peptide receptor B (NPR-B).
- Performed organ culture experiments with fetal mouse tibial explants.
Main Results:
- Sacubitril administration resulted in dose-dependent skeletal overgrowth in mice.
- Histology showed thickened proliferative and hypertrophic zones in the growth plate.
- The growth-promoting effect of sacubitril was abolished in NPR-B knockout mice.
- Skeletal growth promotion was observed in 3-4 week old mice with high endogenous CNP and NEP levels.
Conclusions:
- NEP inhibition significantly promotes skeletal growth via the CNP/NPR-B signaling pathway.
- Targeting NEP offers a potential therapeutic strategy for conditions characterized by impaired skeletal growth.
- Further research is warranted for clinical applications in individuals with short stature.
Related Concept Videos
01:17Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:28Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
01:25cAMP-dependent Protein Kinase Pathways
6.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K